Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Analysis of the Secretome of Primary CLL Cells in Different in Vitro Co-Culture Systems

Lena Osswald, Piero Giansanti, Florian Bassermann, Marc Schmidt-Supprian

Blood (2024) 144 (Supplement 1): 6764.

https://doi.org/10.1182/blood-2024-209875

Published: 2024

Journal Articles

Loss of Microbiota-Derived Metabolites Is Associated with Mucosal-Barrier-Injury Bloodstream Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2024) 144 (Supplement 1): 4904.

https://doi.org/10.1182/blood-2024-193273

Published: 2024

Journal Articles

Omitting Ciprofloxacin Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Result in Inferior Outcomes

Krischan Braitsch, Vanessa Nehrbaß, Katharina Nickel, Maike Hefter, Katrin Koch, Kathrin Rothe, Florian Bassermann, Jochen Schneider, Katharina S. Götze, Peter Herhaus, Mareike Verbeek

Blood (2024) 144 (Supplement 1): 3513.

https://doi.org/10.1182/blood-2024-210620

Published: 2024

Journal Articles

Epigenetic Modifications As a Mechanism of Resistance to BCMA-Directed Immunotherapies in Multiple Myeloma: Insights from Multi-Omic Profiling

Larissa Haertle, Natalia Buenache Cuenda, Isabel Espejo Diaz, Paula Lázaro Del Campo, Andres Arroyo-Barea, Leonie Rieger, Juan Manuel Rosa-Rosa, Rafael Alonso Fernandez, Nieves Lopez, José Sanchez-Pina, Almudena García-Ortiz, Antonio Valeri, Santiago Barrio, Fatima Al-Shahrour, Florian Bassermann, Joaquin Martínez-López, Tomas Di Domenico

Blood (2024) 144 (Supplement 1): 5794.

https://doi.org/10.1182/blood-2024-198117

Published: 2024

Journal Articles

Pre-Apheresis Prediction of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Blood (2024) 144 (Supplement 1): 895.

https://doi.org/10.1182/blood-2024-208376

Published: 2024

Journal Articles

Recovery of the Intestinal Microbiome in Patients at Day +100 after Allogeneic Stem Cell Transplantation Is Defined By Microbial Metabolite Profiles and Linked to Long-Term Outcomes

Blood (2024) 144 (Supplement 1): 780.

https://doi.org/10.1182/blood-2024-199035

Published: 2024

Journal Articles

Immunomodulatory Microbial Metabolites Protect Against Graft-Vs-Host Disease and Enhance Anti-Leukemia Responses in Mice and Patients Receiving Stem Cell Transplantation

Sascha Göttert, Erik Thiele-Orberg, Kaiji Fan, Paul Heinrich, Daniel Wolff, Daniela Weber, Florian Bassermann, Petra Hoffmann, Matthias Edinger, Natalie Koehler, André Gessner, Wolfgang Herr, Simon M Heidegger, Ernst Holler, Hendrik Poeck

Blood (2024) 144 (Supplement 1): 264.

https://doi.org/10.1182/blood-2024-205921

Published: 2024

Journal Articles

Synergistic Activities of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma Converge in the Unfolded Protein Response

Marlene Tietje, Nadine Glaisner, Leonie Rieger, Priska Auf der Maur, Ria Spallek, Marion Hoegner, Ruth Eichner, Florian Bassermann

Blood (2024) 144 (Supplement 1): 6855.

https://doi.org/10.1182/blood-2024-210035

Published: 2024

Journal Articles

Phase 2 Study of Teclistamab-Based Induction Regimens in Patients with Transplant-Eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the GMMG-HD10/DSMM-XX (MajesTEC-5) Trial

Blood (2024) 144 (Supplement 1): 493.

https://doi.org/10.1182/blood-2024-206003

Published: 2024

Journal Articles

Prevalence and Mutational Make-up of Secondary Hematologic Neoplasms in Multiple Myeloma Patients after CAR-T Cell Therapy

Blood (2024) 144 (Supplement 1): 4688.

https://doi.org/10.1182/blood-2024-210233

Published: 2024

Journal Articles

Regulation of BCMA By the Ubiquitin Proteasome System Enables Optimization of BCMA-Targeting Therapies in Multiple Myeloma

Leonie Rieger, Kilian Irlinger, Franziska Fuechsl, Nicolas Barbian, Marlene Tietje, Melanie Faber, Tobias Schulze, Piero Giansanti, Lenka Besse, Christoph Driessen, Angela Krackhardt, Bernhard Kuster, Florian Bassermann

Blood (2023) 142 (Supplement 1): 3310.

https://doi.org/10.1182/blood-2023-187349

Published: 2023

Journal Articles

Leukemic Cell-Intrinsic Innate Nucleic Acid Receptor Signaling Governs Efficacy of Hypomethylating Agents and Immunosurveillance in AML

Nadia El Khawanky, Yunus Barth, Tatiana Nedelko, Marc Rosenbaum, Christin Weiß, Stefan Enßle, Jürgen Ruland, Florian Bassermann, Simon M Heidegger

Blood (2023) 142 (Supplement 1): 1421.

https://doi.org/10.1182/blood-2023-182567

Published: 2023

Journal Articles

Real-World Analysis of Teclistamab in 115 RRMM Patients from Germany

Blood (2023) 142 (Supplement 1): 3329.

https://doi.org/10.1182/blood-2023-180032

Published: 2023

Journal Articles

Bacterial and Bacteriophage Consortia Are Associated with Protective Intestinal Immuno-Modulatory Metabolites in Allogeneic Stem Cell Transplantation Patients

Blood (2023) 142 (Supplement 1): 477.

https://doi.org/10.1182/blood-2023-172457

Published: 2023

Journal Articles

Identification of Bacterial and Viral Consortia for the Production of Intestinal Microbiota-Derived Metabolites Associated with Protection in Allogeneic Stem Cell Transplantation Patients

Blood (2022) 140 (Supplement 1): 7619–7621.

https://doi.org/10.1182/blood-2022-157423

Published: 2022

Journal Articles

Single Cell Transcriptomic Analysis of the Bone Marrow Microenvironment Uncovers a Role for Antigen Presentation Processes in MDS/AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Jennifer Rivière, Mark van der Garde, Judith S. Hecker, Michèle C. Buck, Florian Bassermann, Mareike Verbeek, Katharina S. Goetze

Blood (2022) 140 (Supplement 1): 2906–2907.

https://doi.org/10.1182/blood-2022-165255

Published: 2022

Journal Articles

Targeting Extracellular Vesicle Secretion in Combination with Venetoclax Synergistically Induces Apoptosis in FLT3-ITD+ AML

Judith S. Hecker, Jennifer Rivière, Mark van der Garde, Michèle C. Buck, Rupert Öllinger, Florian Bassermann, Bernd Giebel, Robert A.J. Oostendorp, Roland Rad, Katharina S. Goetze

Blood (2022) 140 (Supplement 1): 8711–8712.

https://doi.org/10.1182/blood-2022-169065

Published: 2022

Journal Articles

Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma

Blood (2022) 140 (Supplement 1): 287–288.

https://doi.org/10.1182/blood-2022-159357

Published: 2022

Journal Articles

Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress

Blood (2022) 139 (5): 690–703.

https://doi.org/10.1182/blood.2021011775

Published: 2022

Includes: Supplemental data

Journal Articles

IFN-Gamma Producing Regulatory T Cells Counterbalance T Cell-Mediated Injury to the Intestinal Stem Cell Compartment in Mice and Humans

Sascha Göttert, Julius Clemens Fischer, Gabriel Eisenkolb, Erik Thiele Orberg, Dirk Busch, Sebastian Jarosch, Ernst Holler, Thomas Engleitner, Lena Klostermeier, Caroline Walther, Laura Lansink Rotgerink, Sophie Nefzger, Marianne Reiser, Katja Steiger, Roland Rad, Stefanie E. Combs, Florian Bassermann, Simon Heidegger, Hendrik Poeck

Blood (2021) 138 (Supplement 1): 89.

https://doi.org/10.1182/blood-2021-152925

Published: 2021

NARROW

Analysis of the Secretome of Primary CLL Cells in Different in Vitro Co-Culture Systems

Loss of Microbiota-Derived Metabolites Is Associated with Mucosal-Barrier-Injury Bloodstream Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Omitting Ciprofloxacin Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Result in Inferior Outcomes

Epigenetic Modifications As a Mechanism of Resistance to BCMA-Directed Immunotherapies in Multiple Myeloma: Insights from Multi-Omic Profiling

Pre-Apheresis Prediction of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Recovery of the Intestinal Microbiome in Patients at Day +100 after Allogeneic Stem Cell Transplantation Is Defined By Microbial Metabolite Profiles and Linked to Long-Term Outcomes

Immunomodulatory Microbial Metabolites Protect Against Graft-Vs-Host Disease and Enhance Anti-Leukemia Responses in Mice and Patients Receiving Stem Cell Transplantation

Synergistic Activities of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma Converge in the Unfolded Protein Response

Phase 2 Study of Teclistamab-Based Induction Regimens in Patients with Transplant-Eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the GMMG-HD10/DSMM-XX (MajesTEC-5) Trial

Prevalence and Mutational Make-up of Secondary Hematologic Neoplasms in Multiple Myeloma Patients after CAR-T Cell Therapy

Regulation of BCMA By the Ubiquitin Proteasome System Enables Optimization of BCMA-Targeting Therapies in Multiple Myeloma

Leukemic Cell-Intrinsic Innate Nucleic Acid Receptor Signaling Governs Efficacy of Hypomethylating Agents and Immunosurveillance in AML

Real-World Analysis of Teclistamab in 115 RRMM Patients from Germany

Bacterial and Bacteriophage Consortia Are Associated with Protective Intestinal Immuno-Modulatory Metabolites in Allogeneic Stem Cell Transplantation Patients

Identification of Bacterial and Viral Consortia for the Production of Intestinal Microbiota-Derived Metabolites Associated with Protection in Allogeneic Stem Cell Transplantation Patients

Single Cell Transcriptomic Analysis of the Bone Marrow Microenvironment Uncovers a Role for Antigen Presentation Processes in MDS/AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Targeting Extracellular Vesicle Secretion in Combination with Venetoclax Synergistically Induces Apoptosis in FLT3-ITD+ AML

Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress

IFN-Gamma Producing Regulatory T Cells Counterbalance T Cell-Mediated Injury to the Intestinal Stem Cell Compartment in Mice and Humans

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only